Indications |
Oral Oedema Adult: Initially, 5-10 mg daily. Start with 2.5 mg once daily if used with other diuretics or antihypertensives. Max: 20 mg daily. Renal impairment: Avoid use. |
Contraindications |
Hyperkalaemia. |
Warnings / Precautions |
DM, elderly, pregnancy and lactation. Discontinue at least 3 days before glucose-tolerance tests are performed. Monitor serum electrolytes regularly. |
Adverse Reactions |
Hyperkalaemia; hyponatraemia; GI disturbances; paraesthesia; thirst; dizziness; skin rash; pruritus; weakness; muscle cramps; headache; minor psychiatric or visual changes; orthostatic hypotension. |
Overdose Reactions |
May result in dehydration and electrolyte imbalance. Treatment is symptomatic and supportive. |
Drug Interactions |
Potassium supplements; other potassium-sparing diuretics; ACE inhibitors, angiotensin II receptor antagonists. Increased risk of nephrotoxicity with NSAIDs. Ciclosporin. Trilostane; other antihypertensives. Severe hyponatraemia with thiazides or chlorpropamide. Reduce ulcer-healing properties of carbenoxolone. See Below for More amiloride Drug Interactions |
Lab Interactions |
Rise in blood-urea-nitrogen concentrations. |
Mechanism of Actions |
Amiloride is a weak diuretic which acts mainly on the distal renal tubules. It increases the excretion of sodium and reduces the excretion of potassium. It diminishes kaliuretic effects of other diuretics, and may produce an additional natriuretic effect. Onset: 2 hr. Duration: 24 hr. Absorption: Bioavailability: about 50%. Excretion: Plasma half-life: 6-9 hr and terminal half-life: about 20 hr or more. Excreted unchanged by the kidneys. |
Administration |
Should be taken with food. |
Storage Conditions |
Oral: Store at 15-30°C. |
ATC Classification |
C03DB01 - amiloride ; Belongs to the class of other potassium-sparing agents. Used as diuretics. |
Storage |
Oral: Store at 15-30°C. |
Available As |
|
Amiloride
Post Review about Amiloride Click here to cancel reply.
Amiloride Containing Brands
Amiloride is used in following diseases
Drug - Drug Interactions of Amiloride
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.